United States · Bill · HR
H.R. 5854 (113th)
To allow the importation, distribution, and sale of investigational drugs and devices intended for use by terminally ill patients who execute an informed consent document.
Introduced
11 December 2014
Last action
11 December 2014 · Introduced
Status
Referred to the House Committee on Energy and Commerce.
Sponsors
Rep. Grayson, Alan [D-FL-9]
Subjects
Healthcare
Source updated
7 April 2025
Summary
Amends the Federal Food, Drug, and Cosmetic Act to declare that nothing in it or in the Public Health Service Act shall prevent or restrict, and the Food and Drug Administration (FDA) shall not implement or enforce any law to prevent or restrict, the importation, distribution, or sale of investigational drugs or devices for terminally ill patients.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
11 December 2014
Introduced
Referred to the House Committee on Energy and Commerce.
Source: IntroReferral
11 December 2014
Introduced
Introduced in House
Source: IntroReferral
11 December 2014
Introduced
Introduced in House
Source: IntroReferral
Votes
No vote records are attached yet.
Versions
- Introduced in House · 11 December 2014 · Official file
Documents
3 official files
Introduced in House (text)
Introduced in House (text)
Introduced in House · EN · 11 December 2014
Introduced in House (PDF)
Introduced in House · EN · 11 December 2014
Introduced in House
summary · EN · 11 December 2014
Sponsors
- Rep. Grayson, Alan [D-FL-9] · D · Sponsor
- · hsif00 · Standing
Related records
- related to → Compassionate Freedom of Choice Act of 2014
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/113th-congress/house-bill/5854
- Open data entity: https://api.congress.gov/v3/bill/113/hr/5854
- us · 113-hr-5854 · source updated 7 April 2025